Oct 13, 2026 07:30AM
Oct 13, 2026 07:30AM
Sep 9, 2026 07:29AM
Sep 9, 2026 04:26AM
Sep 8, 2026 08:10AM
Aug 6, 2026 07:00AM
Jun 13, 2026 07:30AM Intellia reports positive Phase 3 results for hereditary angioedema treatment
Jun 13, 2026 07:30AM
Jun 1, 2026 07:30AM
Jun 1, 2026 07:30AM
May 11, 2026 07:30AM
Apr 27, 2026 02:50PM
Apr 27, 2026 10:10AM
Apr 27, 2026 07:03AM Intellia begins rolling FDA submission for gene editing therapy
Apr 27, 2026 07:00AM
Apr 27, 2026 07:00AM
Apr 27, 2026 07:00AM
Apr 8, 2026 09:15AM
Mar 4, 2026 06:01AM
Mar 3, 2026 09:54AM
Mar 3, 2026 07:30AM Intellia presents longer-term data for hereditary angioedema treatment
Mar 3, 2026 07:30AM
Mar 3, 2026 04:56AM
Mar 2, 2026 03:25PM
Mar 2, 2026 02:48PM
Mar 2, 2026 02:18PM
Mar 2, 2026 02:04PM
Mar 2, 2026 12:28PM Goldman on Intellia Therapeutics (NTLA): 'While shares are trading higher after the news, safety could remain an overhang given the specific risk factors'
Mar 2, 2026 12:05PM
Mar 2, 2026 10:25AM
Mar 2, 2026 07:30AM
Mar 2, 2026 07:30AM
Feb 26, 2026 01:28PM
Feb 26, 2026 07:30AM
Jan 27, 2026 11:29AM Intellia Therapeutics (NTLA) PT Raised to $7 at Baird
Jan 27, 2026 08:00AM
Jan 27, 2026 08:00AM
Dec 19, 2025 09:06AM
Nov 18, 2025 08:45AM
Nov 10, 2025 03:17PM
Nov 10, 2025 03:17PM
Nov 8, 2025 05:13PM Intellia presents positive data for hereditary angioedema treatment
Nov 8, 2025 05:13PM
Nov 7, 2025 08:56AM
Nov 6, 2025 04:00PM
Oct 31, 2025 09:54AM
Oct 31, 2025 07:27AM
Oct 30, 2025 04:55AM
Oct 29, 2025 04:24PM FDA places clinical hold on Intellia's MAGNITUDE trials for nex-z
Oct 28, 2025 06:26AM

334,268 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All